Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2523PDF: 1026HTML: 94 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1318PDF: 782HTML: 3100 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3116PDF: 963HTML: 1986 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
927PDF: 799Suppl. Files: 436HTML: 270 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2604PDF: 955HTML: 2151 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1516PDF: 842HTML: 3143Figure 5: 143Figure 4: 140Figure 3: 171Figure 1: 154Figure 2: 145 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3751PDF: 1401HTML: 8482 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1544PDF: 755HTML: 1218Figure 1: 139Figure 2: 160Figure 3: 163 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
838PDF: 425HTML: 101 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1298PDF: 1263HTML: 77 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1743PDF: 802HTML: 1547 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3258PDF: 561HTML: 628 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1467PDF: 812HTML: 1010Picture 1: 150 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1478PDF: 939HTML: 144 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1755PDF: 773HTML: 3580 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
699PDF: 450HTML: 6243 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4129PDF: 1118HTML: 2115Figure 1: 144 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1330PDF: 1150HTML: 480 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4300PDF: 1859HTML: 17705 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7607PDF: 3923HTML: 7277 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1484PDF: 1228HTML: 125 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1098PDF: 794HTML: 2163Figue 1: 157 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1111PDF: 754HTML: 1753







